Breast Cancer Clinical Trials

NRG BR002

A Phase IIR/III Trial of Standard of Care Therapy with or Without SBRT and/or Surgical Ablation for Newly Oligometastatic Breast Cancer

Learn more.


NSABP B-55

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Multi-Center Phase III Study to Assess the Efficacy and Safety of Olaparib vs Placebo as Adjuvant Treatment in Patients with BRCA ½ Mutations and High Risk HER2 Negative Primary Breast Cancer Who have Completed Definitive Local Treatment and Neoadjuvant or Adjuvant Chemotherapy

Learn more.


A011202

A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

Learn more.


A011401

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer

Learn more.


A011106

Alternate approaches for clinical stage II and III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women:  A Phase III study

Learn more.


A011502

A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin As Adjuvant Therapy For HER2 Negative Breast Cancer:  The ABC Trial

Learn more.


J13104 (IU study)

A Randomized Phase II Study of Partial Breast Irradiation and Sequential vs. Concurrent Chemotherapy in Women with Early Stage Breast Cancer

Learn more.


A011104

Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer

Learn more.

Need assistance?

Contact us